Jon Treffert was diagnosed with locally advanced muscle-invasive bladder cancer in September 2023. After 2 years of treatment, including surgical resection and 6 months with an antibody-drug conjugate (ADC), he had no evidence of disease and an intact bladder. In this episode, CANCER BUZZ speaks with Treffert about his experience receiving ADCs and how he is using his platform as a patient advocate to support other patients make informed decisions about their bladder cancer care.
“I'm trying to build a community, a cohort of people like myself, who have chosen to keep their bladder, have had a complete response to EVP, and try to share lived experience.” —Jon Treffert
“One piece of advice I always give is tell your care team anytime you have something that's out of the ordinary.” —Jon Treffert
Guest:
Jon Treffert
Bladder Cancer Patient Advocate
Powell, TN
Resources:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
June 30, 2026
